Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The Middle East veterinary vaccine industry size is projected to expand at a 4% CAGR through 2033. The demand outlook for veterinary vaccines in the Middle East is US$ 627.1 million in 2023. By 2033, sales of veterinary vaccines in the Middle East are anticipated to cross a valuation of US$ 973.8 million.
Attributes | Details |
---|---|
Middle East Veterinary Vaccine Industry Size in 2023 | US$ 627.1 million |
Expected Industry Size by 2033 | US$ 973.8 million |
Value-based CAGR from 2023 to 2033 | 4% |
Key Trends Influencing Demand through 2033
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Attributes | Details |
---|---|
Middle East Veterinary Vaccine Industry Size (2018) | US$ 510.8 million |
Middle East Veterinary Vaccine Industry Size (2022) | US$ 627.1 million |
The Middle East's livestock and agriculture industries have grown significantly in recent years due to rising demand for meat, dairy, and other animal-based products. This developing industry requires the use of veterinary vaccinations to ensure the health and productivity of animals, consequently stimulating the veterinary vaccine sector's growth. Biosecurity and disease management have become critical in the livestock and agriculture industries of the Middle East. Robust procedures, including vaccination, are required to prevent disease spread within and across animal populations, fueling industry growth.
Businesses in the Middle East veterinary vaccine industry are vying to minimize the environmental effect of vaccine manufacturing and distribution as sustainability goals gain importance in the Middle East. Green practices and eco-friendly solutions are in line with the region's environmental goals. Animal disease outbreaks can have significant economic and public health consequences in the Middle East. By guaranteeing animal health through vaccination, the region mitigates these dangers while protecting the food supply and public health interests.
In the coming years, the global demand for animal-based protein is predicted to rise further as the world's population grows with rising incomes. This will increase the demand for efficient disease prevention methods such as veterinary vaccinations. Biotechnology, genetics, and immunology advancements result in the development of more accurate, efficacious, and novel veterinary vaccines. These innovations improve the industry's capacity to tackle new and emerging illnesses. Recognizing the interconnection of human, animal, and environmental health, the One Health concept is expected to foster collaboration between the veterinary and human health sectors for disease management initiatives.
Two industries related to the Veterinary Vaccine and Veterinary Hospital industries. As per the analysis, the rising pet adoption is anticipated to fuel expansion across the mentioned industries. The rising advancements in animal health monitoring and disease surveillance are expected to boost revenues across these industries. The ongoing developments in vaccine production are expected to influence growth across these industries. The rising awareness for animal welfare will also gain prominence and create opportunities across these industries in the coming years.
Middle East Veterinary Vaccine Industry:
Attributes | Middle East Veterinary Vaccine Industry |
---|---|
CAGR (2023 to 2033) | 4% |
Market Value (2023) | US$ 627.1 million |
Growth Factors | Increasing investment in aquaculture Rising focus on livestock health |
Future Opportunities | Development of halal-certified veterinary vaccines |
Market Trends | Advancements in disease forecasting and monitoring solutions |
Veterinary Vaccine Industry:
Attributes | Veterinary Vaccine Industry |
---|---|
CAGR (2023 to 2033) | 6.2% |
Market Value (2023) | US$ 11.3 billion |
Growth Factors | Increasing expenditure on pet care Rising adoption of efficient immunizations |
Future Opportunities | Increased government investments |
Market Trends | Rising advancements in vaccine development |
Veterinary Hospital Industry:
Attributes | Veterinary Hospital Industry |
---|---|
CAGR (2023 to 2033) | 6.2% |
Market Value (2023) | US$ 79.54 billion |
Growth Factors | Continued modernization of advanced veterinary healthcare infrastructure. Increasing pet adoption globally. |
Future Opportunities | Increased veterinary healthcare expenditure. |
Market Trends | Growing awareness for animal welfare. |
Leading Vaccine Technology in the Middle East | Attenuated Live Vaccines Technology |
---|---|
Total Value Share (2023) | 34.20% |
The Middle East's surging investments in biotechnology and research are boosting the domestic production of attenuated live vaccines. This coincides with the region's objective of vaccine self-sufficiency and enables customization to meet particular area disease issues. Live attenuated vaccines have proven to be useful in preventing a variety of animal illnesses. They provide a cost-effective disease management option, which is especially tempting in the Middle East's livestock and agriculture industries, where economic concerns are essential.
Leading Animal Type in the Middle East | Livestock Animals |
---|---|
Total Value Share (2023) | 74.40% |
Governments around the Middle East are fiercely encouraging the expansion of the livestock sector, with many of their activities involving disease control through vaccination campaigns. The Middle East is home to a diversified animal population, which includes cattle, sheep, goats, and even camels. Each species has unique disease problems, requiring a range of vaccinations carefully tailored to each animal type's needs. Several Middle Eastern nations are making huge investments in agriculture and animal husbandry to improve food security. As the livestock industry grows, the demand for veterinary vaccinations to protect animal health and production aligns with national food security goals.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Countries | Value-based CAGR (2023 to 2033) |
---|---|
KSA | 4.9% |
UAE | 5.1% |
Iran | 4.3% |
Israel | 4.0% |
Egypt | 5.3% |
Sales of veterinary vaccines in the Kingdom of Saudi Arabia (KSA) are expected to rise at a 4.9% CAGR through 2033. The Kingdom of Saudi Arabia's Vision 2030 strategic efforts focus on non-oil industries such as agriculture and healthcare. This commitment drives investments in the veterinary vaccine business, aligning with the country's economic diversification objectives. Royal support for agriculture, particularly animal husbandry, leads to greater financing and incentives for veterinary vaccine research and manufacturing. This royal encouragement has created a favorable atmosphere for the growth of the veterinary vaccine sector.
The UAE veterinary vaccines industry is projected to expand at a 5.1% CAGR through 2033. The UAE's emphasis on genetic development in livestock breeds to increase performance has increased the demand for vaccinations that protect genetically superior animals. As a result, customized vaccinations that target these breeds' specific health needs are gaining popularity. The UAE's efforts in state-of-the-art research and development, including genomics and biotechnology, have sparked the development of novel vaccinations suited to the particular animal health issues in the area. These developments are attracting both domestic and international stakeholders.
Sales of veterinary vaccines in Iran are expected to rise at a 4.3% CAGR through 2033. Iran has been subjected to international sanctions, driving self-sufficiency measures in a variety of industries, including healthcare. These self-sufficiency programs have supported the veterinary vaccine sector, leading to greater domestic manufacturing and an emphasis on innovation. The strategic location of Iran serves as a gateway for trade for Asia, Europe, and the Middle East. As trade networks increase, there is a greater demand for livestock vaccination to fulfill international animal health standards and enable commerce, hence promoting the expansion of the veterinary vaccine industry.
The demand for veterinary vaccines in Israel is likely to increase at a 4.0% CAGR through 2033. However, in light of recent geopolitical tensions between Israel and its neighboring countries, revenues of several industries are expected to be affected. Despite this, the Israeli government's significant emphasis on national security extends to biosecurity issues. The veterinary vaccine sector is vital in preserving cattle and animal populations, guaranteeing food security, and preventing bioterrorism.
The veterinary vaccine industry in Egypt is anticipated to accelerate at a 5.3% CAGR through 2033. The Egyptian government's emphasis on food security and self-sufficiency encourages investments in the livestock sector and the veterinary vaccination business. The industry is critical to ensuring the health and well-being of cattle, therefore contributing to the nation's food security goals. Egypt's participation in Pan-African agricultural projects and collaborations has resulted in a rising need for vaccinations that are compliant with regional disease control and trade standards, establishing the country as a prominent participant in African agriculture.
The Middle East veterinary vaccines industry's competitive environment is defined by a broad array of players and entities, each of which contributes to the sector's growth and development. Multinational pharmaceutical conglomerates like Zoetis, MSD Animal Health (Merck Animal Health in the United States and Canada), and Boehringer Ingelheim have a prominent presence in the region. These firms provide a wide range of vaccines, building on established brand awareness using their global reach and substantial research capabilities. Key players provide complete solutions to a wide range of animal health issues across the Middle East.
Recent Developments in the Middle East Veterinary Vaccine Industry
The Middle East veterinary vaccine market size is US$ 627.1 million in 2023.
The Middle East veterinary vaccine market is expected to rise at a 4% CAGR through 2033.
The Middle East veterinary vaccine market size will be worth US$ 973.8 million by 2033.
The demand for attenuated live vaccine technology is high in the industry.
The Middle East veterinary vaccine market size in Egypt is expected to rise at a 5.3% CAGR through 2033.
1. Executive Summary 1.1. Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Vaccine 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Vaccine, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Vaccine, 2023 to 2033 5.3.1. Attenuated Live Vaccines 5.3.2. Inactivated Vaccines 5.3.3. Toxoid Vaccines 5.3.4. DNA Vaccines 5.3.5. Recombinant Vaccines 5.3.6. Others 5.4. Y-o-Y Growth Trend Analysis By Vaccine, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Vaccine, 2023 to 2033 6. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Animal, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Animal, 2023 to 2033 6.3.1. Companion Animals 6.3.1.1. Canine 6.3.1.2. Avian 6.3.1.3. Feline 6.3.2. Livestock Animals 6.3.2.1. Aquatic 6.3.2.2. Bovine 6.3.2.3. Porcine 6.3.2.4. Small Ruminant 6.3.2.5. Poultry 6.3.3. Equine 6.4. Y-o-Y Growth Trend Analysis By Animal, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Animal, 2023 to 2033 7. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Indication 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Disease Indication, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Disease Indication, 2023 to 2033 7.3.1. Foot and Mouth Disease 7.3.2. Newcastle Disease 7.3.3. PPRS 7.3.4. Canine Parvovirus 7.3.5. Brucellosis 7.3.6. Avian Influenza 7.3.7. Others 7.4. Y-o-Y Growth Trend Analysis By Disease Indication, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Disease Indication, 2023 to 2033 8. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033 8.3.1. Hospital Pharmacies 8.3.2. Veterinary Clinics 8.3.3. Private Veterinary Pharmacies 8.3.4. Others 8.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033 9. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 9.3.1. UAE 9.3.2. KSA 9.3.3. Turkey 9.3.4. Jordan 9.3.5. Sudan 9.3.6. Egypt 9.3.7. Rest of Middle East 9.4. Market Attractiveness Analysis By Region 10. UAE Market Analysis 2018 to 2022 and Forecast 2023 to 2033 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.2. By Vaccine 10.2.3. By Animal 10.2.4. By Disease Indication 10.2.5. By End-User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Vaccine 10.3.3. By Animal 10.3.4. By Disease Indication 10.3.5. By End-User 10.4. Key Takeaways 11. KSA Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.2. By Vaccine 11.2.3. By Animal 11.2.4. By Disease Indication 11.2.5. By End-User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Vaccine 11.3.3. By Animal 11.3.4. By Disease Indication 11.3.5. By End-User 11.4. Key Takeaways 12. Turkey Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.2. By Vaccine 12.2.3. By Animal 12.2.4. By Disease Indication 12.2.5. By End-User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Vaccine 12.3.3. By Animal 12.3.4. By Disease Indication 12.3.5. By End-User 12.4. Key Takeaways 13. Jordan Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.2. By Vaccine 13.2.3. By Animal 13.2.4. By Disease Indication 13.2.5. By End-User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Vaccine 13.3.3. By Animal 13.3.4. By Disease Indication 13.3.5. By End-User 13.4. Key Takeaways 14. Sudan Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.2. By Vaccine 14.2.3. By Animal 14.2.4. By Disease Indication 14.2.5. By End-User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Vaccine 14.3.3. By Animal 14.3.4. By Disease Indication 14.3.5. By End-User 14.4. Key Takeaways 15. Egypt Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.2. By Vaccine 15.2.3. By Animal 15.2.4. By Disease Indication 15.2.5. By End-User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Vaccine 15.3.3. By Animal 15.3.4. By Disease Indication 15.3.5. By End-User 15.4. Key Takeaways 16. Rest of Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.2. By Vaccine 16.2.3. By Animal 16.2.4. By Disease Indication 16.2.5. By End-User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Vaccine 16.3.3. By Animal 16.3.4. By Disease Indication 16.3.5. By End-User 16.4. Key Takeaways 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Vaccine 17.3.3. By Animal 17.3.4. By Disease Indication 17.3.5. By End-User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. JOVAC 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Bioveta, Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Intervac Pvt. Ltd. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Zoetis 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Elanco 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Merial 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Merck & Co. Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Bayer Pharma AG 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Ceva 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Boehringer Ingelheim 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Table 1: Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Market Volume (Units) Forecast by Region, 2018 to 2033 Table 3: Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033 Table 4: Market Volume (Units) Forecast by Vaccine, 2018 to 2033 Table 5: Market Value (US$ Million) Forecast by Animal, 2018 to 2033 Table 6: Market Volume (Units) Forecast by Animal, 2018 to 2033 Table 7: Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 8: Market Volume (Units) Forecast by Disease Indication, 2018 to 2033 Table 9: Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 10: Market Volume (Units) Forecast by End-User, 2018 to 2033 Table 11: UAE Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 12: UAE Market Volume (Units) Forecast by Country, 2018 to 2033 Table 13: UAE Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033 Table 14: UAE Market Volume (Units) Forecast by Vaccine, 2018 to 2033 Table 15: UAE Market Value (US$ Million) Forecast by Animal, 2018 to 2033 Table 16: UAE Market Volume (Units) Forecast by Animal, 2018 to 2033 Table 17: UAE Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 18: UAE Market Volume (Units) Forecast by Disease Indication, 2018 to 2033 Table 19: UAE Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 20: UAE Market Volume (Units) Forecast by End-User, 2018 to 2033 Table 21: KSA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: KSA Market Volume (Units) Forecast by Country, 2018 to 2033 Table 23: KSA Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033 Table 24: KSA Market Volume (Units) Forecast by Vaccine, 2018 to 2033 Table 25: KSA Market Value (US$ Million) Forecast by Animal, 2018 to 2033 Table 26: KSA Market Volume (Units) Forecast by Animal, 2018 to 2033 Table 27: KSA Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 28: KSA Market Volume (Units) Forecast by Disease Indication, 2018 to 2033 Table 29: KSA Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 30: KSA Market Volume (Units) Forecast by End-User, 2018 to 2033 Table 31: Turkey Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 32: Turkey Market Volume (Units) Forecast by Country, 2018 to 2033 Table 33: Turkey Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033 Table 34: Turkey Market Volume (Units) Forecast by Vaccine, 2018 to 2033 Table 35: Turkey Market Value (US$ Million) Forecast by Animal, 2018 to 2033 Table 36: Turkey Market Volume (Units) Forecast by Animal, 2018 to 2033 Table 37: Turkey Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 38: Turkey Market Volume (Units) Forecast by Disease Indication, 2018 to 2033 Table 39: Turkey Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 40: Turkey Market Volume (Units) Forecast by End-User, 2018 to 2033 Table 41: Jordan Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 42: Jordan Market Volume (Units) Forecast by Country, 2018 to 2033 Table 43: Jordan Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033 Table 44: Jordan Market Volume (Units) Forecast by Vaccine, 2018 to 2033 Table 45: Jordan Market Value (US$ Million) Forecast by Animal, 2018 to 2033 Table 46: Jordan Market Volume (Units) Forecast by Animal, 2018 to 2033 Table 47: Jordan Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 48: Jordan Market Volume (Units) Forecast by Disease Indication, 2018 to 2033 Table 49: Jordan Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 50: Jordan Market Volume (Units) Forecast by End-User, 2018 to 2033 Table 51: Sudan Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 52: Sudan Market Volume (Units) Forecast by Country, 2018 to 2033 Table 53: Sudan Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033 Table 54: Sudan Market Volume (Units) Forecast by Vaccine, 2018 to 2033 Table 55: Sudan Market Value (US$ Million) Forecast by Animal, 2018 to 2033 Table 56: Sudan Market Volume (Units) Forecast by Animal, 2018 to 2033 Table 57: Sudan Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 58: Sudan Market Volume (Units) Forecast by Disease Indication, 2018 to 2033 Table 59: Sudan Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 60: Sudan Market Volume (Units) Forecast by End-User, 2018 to 2033 Table 61: Egypt Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 62: Egypt Market Volume (Units) Forecast by Country, 2018 to 2033 Table 63: Egypt Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033 Table 64: Egypt Market Volume (Units) Forecast by Vaccine, 2018 to 2033 Table 65: Egypt Market Value (US$ Million) Forecast by Animal, 2018 to 2033 Table 66: Egypt Market Volume (Units) Forecast by Animal, 2018 to 2033 Table 67: Egypt Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 68: Egypt Market Volume (Units) Forecast by Disease Indication, 2018 to 2033 Table 69: Egypt Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 70: Egypt Market Volume (Units) Forecast by End-User, 2018 to 2033 Table 71: Rest of Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 72: Rest of Market Volume (Units) Forecast by Country, 2018 to 2033 Table 73: Rest of Market Value (US$ Million) Forecast by Vaccine, 2018 to 2033 Table 74: Rest of Market Volume (Units) Forecast by Vaccine, 2018 to 2033 Table 75: Rest of Market Value (US$ Million) Forecast by Animal, 2018 to 2033 Table 76: Rest of Market Volume (Units) Forecast by Animal, 2018 to 2033 Table 77: Rest of Market Value (US$ Million) Forecast by Disease Indication, 2018 to 2033 Table 78: Rest of Market Volume (Units) Forecast by Disease Indication, 2018 to 2033 Table 79: Rest of Market Value (US$ Million) Forecast by End-User, 2018 to 2033 Table 80: Rest of Market Volume (Units) Forecast by End-User, 2018 to 2033
Figure 1: Market Value (US$ Million) by Vaccine, 2023 to 2033 Figure 2: Market Value (US$ Million) by Animal, 2023 to 2033 Figure 3: Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 4: Market Value (US$ Million) by End-User, 2023 to 2033 Figure 5: Market Value (US$ Million) by Region, 2023 to 2033 Figure 6: Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 7: Market Volume (Units) Analysis by Region, 2018 to 2033 Figure 8: Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 9: Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 10: Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033 Figure 11: Market Volume (Units) Analysis by Vaccine, 2018 to 2033 Figure 12: Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033 Figure 13: Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033 Figure 14: Market Value (US$ Million) Analysis by Animal, 2018 to 2033 Figure 15: Market Volume (Units) Analysis by Animal, 2018 to 2033 Figure 16: Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033 Figure 17: Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033 Figure 18: Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 19: Market Volume (Units) Analysis by Disease Indication, 2018 to 2033 Figure 20: Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 21: Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 22: Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 23: Market Volume (Units) Analysis by End-User, 2018 to 2033 Figure 24: Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 25: Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 26: Market Attractiveness by Vaccine, 2023 to 2033 Figure 27: Market Attractiveness by Animal, 2023 to 2033 Figure 28: Market Attractiveness by Disease Indication, 2023 to 2033 Figure 29: Market Attractiveness by End-User, 2023 to 2033 Figure 30: Market Attractiveness by Region, 2023 to 2033 Figure 31: UAE Market Value (US$ Million) by Vaccine, 2023 to 2033 Figure 32: UAE Market Value (US$ Million) by Animal, 2023 to 2033 Figure 33: UAE Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 34: UAE Market Value (US$ Million) by End-User, 2023 to 2033 Figure 35: UAE Market Value (US$ Million) by Country, 2023 to 2033 Figure 36: UAE Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 37: UAE Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 38: UAE Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 39: UAE Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 40: UAE Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033 Figure 41: UAE Market Volume (Units) Analysis by Vaccine, 2018 to 2033 Figure 42: UAE Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033 Figure 43: UAE Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033 Figure 44: UAE Market Value (US$ Million) Analysis by Animal, 2018 to 2033 Figure 45: UAE Market Volume (Units) Analysis by Animal, 2018 to 2033 Figure 46: UAE Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033 Figure 47: UAE Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033 Figure 48: UAE Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 49: UAE Market Volume (Units) Analysis by Disease Indication, 2018 to 2033 Figure 50: UAE Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 51: UAE Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 52: UAE Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 53: UAE Market Volume (Units) Analysis by End-User, 2018 to 2033 Figure 54: UAE Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 55: UAE Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 56: UAE Market Attractiveness by Vaccine, 2023 to 2033 Figure 57: UAE Market Attractiveness by Animal, 2023 to 2033 Figure 58: UAE Market Attractiveness by Disease Indication, 2023 to 2033 Figure 59: UAE Market Attractiveness by End-User, 2023 to 2033 Figure 60: UAE Market Attractiveness by Country, 2023 to 2033 Figure 61: KSA Market Value (US$ Million) by Vaccine, 2023 to 2033 Figure 62: KSA Market Value (US$ Million) by Animal, 2023 to 2033 Figure 63: KSA Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 64: KSA Market Value (US$ Million) by End-User, 2023 to 2033 Figure 65: KSA Market Value (US$ Million) by Country, 2023 to 2033 Figure 66: KSA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 67: KSA Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 68: KSA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 69: KSA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 70: KSA Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033 Figure 71: KSA Market Volume (Units) Analysis by Vaccine, 2018 to 2033 Figure 72: KSA Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033 Figure 73: KSA Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033 Figure 74: KSA Market Value (US$ Million) Analysis by Animal, 2018 to 2033 Figure 75: KSA Market Volume (Units) Analysis by Animal, 2018 to 2033 Figure 76: KSA Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033 Figure 77: KSA Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033 Figure 78: KSA Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 79: KSA Market Volume (Units) Analysis by Disease Indication, 2018 to 2033 Figure 80: KSA Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 81: KSA Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 82: KSA Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 83: KSA Market Volume (Units) Analysis by End-User, 2018 to 2033 Figure 84: KSA Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 85: KSA Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 86: KSA Market Attractiveness by Vaccine, 2023 to 2033 Figure 87: KSA Market Attractiveness by Animal, 2023 to 2033 Figure 88: KSA Market Attractiveness by Disease Indication, 2023 to 2033 Figure 89: KSA Market Attractiveness by End-User, 2023 to 2033 Figure 90: KSA Market Attractiveness by Country, 2023 to 2033 Figure 91: Turkey Market Value (US$ Million) by Vaccine, 2023 to 2033 Figure 92: Turkey Market Value (US$ Million) by Animal, 2023 to 2033 Figure 93: Turkey Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 94: Turkey Market Value (US$ Million) by End-User, 2023 to 2033 Figure 95: Turkey Market Value (US$ Million) by Country, 2023 to 2033 Figure 96: Turkey Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 97: Turkey Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 98: Turkey Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 99: Turkey Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 100: Turkey Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033 Figure 101: Turkey Market Volume (Units) Analysis by Vaccine, 2018 to 2033 Figure 102: Turkey Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033 Figure 103: Turkey Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033 Figure 104: Turkey Market Value (US$ Million) Analysis by Animal, 2018 to 2033 Figure 105: Turkey Market Volume (Units) Analysis by Animal, 2018 to 2033 Figure 106: Turkey Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033 Figure 107: Turkey Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033 Figure 108: Turkey Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 109: Turkey Market Volume (Units) Analysis by Disease Indication, 2018 to 2033 Figure 110: Turkey Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 111: Turkey Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 112: Turkey Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 113: Turkey Market Volume (Units) Analysis by End-User, 2018 to 2033 Figure 114: Turkey Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 115: Turkey Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 116: Turkey Market Attractiveness by Vaccine, 2023 to 2033 Figure 117: Turkey Market Attractiveness by Animal, 2023 to 2033 Figure 118: Turkey Market Attractiveness by Disease Indication, 2023 to 2033 Figure 119: Turkey Market Attractiveness by End-User, 2023 to 2033 Figure 120: Turkey Market Attractiveness by Country, 2023 to 2033 Figure 121: Jordan Market Value (US$ Million) by Vaccine, 2023 to 2033 Figure 122: Jordan Market Value (US$ Million) by Animal, 2023 to 2033 Figure 123: Jordan Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 124: Jordan Market Value (US$ Million) by End-User, 2023 to 2033 Figure 125: Jordan Market Value (US$ Million) by Country, 2023 to 2033 Figure 126: Jordan Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 127: Jordan Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 128: Jordan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 129: Jordan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 130: Jordan Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033 Figure 131: Jordan Market Volume (Units) Analysis by Vaccine, 2018 to 2033 Figure 132: Jordan Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033 Figure 133: Jordan Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033 Figure 134: Jordan Market Value (US$ Million) Analysis by Animal, 2018 to 2033 Figure 135: Jordan Market Volume (Units) Analysis by Animal, 2018 to 2033 Figure 136: Jordan Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033 Figure 137: Jordan Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033 Figure 138: Jordan Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 139: Jordan Market Volume (Units) Analysis by Disease Indication, 2018 to 2033 Figure 140: Jordan Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 141: Jordan Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 142: Jordan Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 143: Jordan Market Volume (Units) Analysis by End-User, 2018 to 2033 Figure 144: Jordan Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 145: Jordan Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 146: Jordan Market Attractiveness by Vaccine, 2023 to 2033 Figure 147: Jordan Market Attractiveness by Animal, 2023 to 2033 Figure 148: Jordan Market Attractiveness by Disease Indication, 2023 to 2033 Figure 149: Jordan Market Attractiveness by End-User, 2023 to 2033 Figure 150: Jordan Market Attractiveness by Country, 2023 to 2033 Figure 151: Sudan Market Value (US$ Million) by Vaccine, 2023 to 2033 Figure 152: Sudan Market Value (US$ Million) by Animal, 2023 to 2033 Figure 153: Sudan Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 154: Sudan Market Value (US$ Million) by End-User, 2023 to 2033 Figure 155: Sudan Market Value (US$ Million) by Country, 2023 to 2033 Figure 156: Sudan Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 157: Sudan Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 158: Sudan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 159: Sudan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 160: Sudan Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033 Figure 161: Sudan Market Volume (Units) Analysis by Vaccine, 2018 to 2033 Figure 162: Sudan Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033 Figure 163: Sudan Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033 Figure 164: Sudan Market Value (US$ Million) Analysis by Animal, 2018 to 2033 Figure 165: Sudan Market Volume (Units) Analysis by Animal, 2018 to 2033 Figure 166: Sudan Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033 Figure 167: Sudan Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033 Figure 168: Sudan Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 169: Sudan Market Volume (Units) Analysis by Disease Indication, 2018 to 2033 Figure 170: Sudan Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 171: Sudan Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 172: Sudan Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 173: Sudan Market Volume (Units) Analysis by End-User, 2018 to 2033 Figure 174: Sudan Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 175: Sudan Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 176: Sudan Market Attractiveness by Vaccine, 2023 to 2033 Figure 177: Sudan Market Attractiveness by Animal, 2023 to 2033 Figure 178: Sudan Market Attractiveness by Disease Indication, 2023 to 2033 Figure 179: Sudan Market Attractiveness by End-User, 2023 to 2033 Figure 180: Sudan Market Attractiveness by Country, 2023 to 2033 Figure 181: Egypt Market Value (US$ Million) by Vaccine, 2023 to 2033 Figure 182: Egypt Market Value (US$ Million) by Animal, 2023 to 2033 Figure 183: Egypt Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 184: Egypt Market Value (US$ Million) by End-User, 2023 to 2033 Figure 185: Egypt Market Value (US$ Million) by Country, 2023 to 2033 Figure 186: Egypt Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 187: Egypt Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 188: Egypt Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 189: Egypt Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 190: Egypt Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033 Figure 191: Egypt Market Volume (Units) Analysis by Vaccine, 2018 to 2033 Figure 192: Egypt Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033 Figure 193: Egypt Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033 Figure 194: Egypt Market Value (US$ Million) Analysis by Animal, 2018 to 2033 Figure 195: Egypt Market Volume (Units) Analysis by Animal, 2018 to 2033 Figure 196: Egypt Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033 Figure 197: Egypt Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033 Figure 198: Egypt Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 199: Egypt Market Volume (Units) Analysis by Disease Indication, 2018 to 2033 Figure 200: Egypt Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 201: Egypt Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 202: Egypt Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 203: Egypt Market Volume (Units) Analysis by End-User, 2018 to 2033 Figure 204: Egypt Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 205: Egypt Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 206: Egypt Market Attractiveness by Vaccine, 2023 to 2033 Figure 207: Egypt Market Attractiveness by Animal, 2023 to 2033 Figure 208: Egypt Market Attractiveness by Disease Indication, 2023 to 2033 Figure 209: Egypt Market Attractiveness by End-User, 2023 to 2033 Figure 210: Egypt Market Attractiveness by Country, 2023 to 2033 Figure 211: Rest of Market Value (US$ Million) by Vaccine, 2023 to 2033 Figure 212: Rest of Market Value (US$ Million) by Animal, 2023 to 2033 Figure 213: Rest of Market Value (US$ Million) by Disease Indication, 2023 to 2033 Figure 214: Rest of Market Value (US$ Million) by End-User, 2023 to 2033 Figure 215: Rest of Market Value (US$ Million) by Country, 2023 to 2033 Figure 216: Rest of Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 217: Rest of Market Volume (Units) Analysis by Country, 2018 to 2033 Figure 218: Rest of Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 219: Rest of Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 220: Rest of Market Value (US$ Million) Analysis by Vaccine, 2018 to 2033 Figure 221: Rest of Market Volume (Units) Analysis by Vaccine, 2018 to 2033 Figure 222: Rest of Market Value Share (%) and BPS Analysis by Vaccine, 2023 to 2033 Figure 223: Rest of Market Y-o-Y Growth (%) Projections by Vaccine, 2023 to 2033 Figure 224: Rest of Market Value (US$ Million) Analysis by Animal, 2018 to 2033 Figure 225: Rest of Market Volume (Units) Analysis by Animal, 2018 to 2033 Figure 226: Rest of Market Value Share (%) and BPS Analysis by Animal, 2023 to 2033 Figure 227: Rest of Market Y-o-Y Growth (%) Projections by Animal, 2023 to 2033 Figure 228: Rest of Market Value (US$ Million) Analysis by Disease Indication, 2018 to 2033 Figure 229: Rest of Market Volume (Units) Analysis by Disease Indication, 2018 to 2033 Figure 230: Rest of Market Value Share (%) and BPS Analysis by Disease Indication, 2023 to 2033 Figure 231: Rest of Market Y-o-Y Growth (%) Projections by Disease Indication, 2023 to 2033 Figure 232: Rest of Market Value (US$ Million) Analysis by End-User, 2018 to 2033 Figure 233: Rest of Market Volume (Units) Analysis by End-User, 2018 to 2033 Figure 234: Rest of Market Value Share (%) and BPS Analysis by End-User, 2023 to 2033 Figure 235: Rest of Market Y-o-Y Growth (%) Projections by End-User, 2023 to 2033 Figure 236: Rest of Market Attractiveness by Vaccine, 2023 to 2033 Figure 237: Rest of Market Attractiveness by Animal, 2023 to 2033 Figure 238: Rest of Market Attractiveness by Disease Indication, 2023 to 2033 Figure 239: Rest of Market Attractiveness by End-User, 2023 to 2033 Figure 240: Rest of Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports